Featured News
TrialHub celebrates five years of increasing access to trials for underserved populations including individuals diagnosed with melanoma, rare cancers and those living in outer metropolitan, regional, rural and remote areas.
We are proud to announce the successful completion of 24-months of follow-up for the IMAGE trial, a landmark study evaluating the role of Melanoma Surveillance Photography (MSP) in improving early detection of melanoma among high and ultra-high-risk patients.
Leading skin care brand Avène has raised nearly $39,000 to support clinical trials led by Melanoma and Skin Cancer Trials.
The Australasian Ocular Melanoma Alliance (AOMA) held an educational gathering in Hobart on the 7th of March.
Led by MASC Trials and Dr Malaka Ameratunga, the BETTER trial aims to improve the care, treatment and quality of life for symptomatic patients with melanoma that has spread to the brain.
To help conquer the urgent problem Australia has with melanoma and skin cancer, leading skin care brand Avène has teamed up with Melanoma and Skin Cancer Trials.
The incredible efforts of the team behind Conquering Skin Cancer were recognised at the 2025 Impact DOCS Awards with Awards of Excellence for Best Documentary Feature and Best Direction. There are also new screening locations and sessions to be held in in South Australia and New South Wales.
After Paul Beard's double lung transplant, the immunosuppressant drugs he needed led to skin cancers. Seeking a solution, Paul enrolled in the SiroSkin clinical trial.
When Illana Klevansky was diagnosed with ocular melanoma, the news was so traumatic that she started a journal to help process her thoughts and fears.
When Ana Ratapu was diagnosed with metastatic melanoma, she had to fight to access life-saving treatment. With the clock ticking and limited treatment options available in New Zealand, Ana made the decision that would save her life: move to Australia and join a clinical trial.